cunningham creek distributors, inc.

799 e. broadway, #3
boston, massachusetts 02127

NYS Entity Status
ACTIVE

NYS Filing Date
DECEMBER 18, 2013

NYS DOS ID#
4502855

County
STEUBEN

Jurisdiction
MASSACHUSETTS

Registered Agent
NONE

NYS Entity Type
FOREIGN BUSINESS CORPORATION

Name History
2013 - CUNNINGHAM CREEK DISTRIBUTORS, INC.









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • AROUND THE WEB

  • Target Pulls Hampton Creek Products From Stores Over Food Safety Concerns
    By Laura Northrup - Friday Jun 23, 2017

    Target, a chain that’s popular because “upscale discount store” is apparently not an oxymoron, is a big seller of Hampton Creek’s vegan food products, including its not-mayonnaise Just Mayo. But now Target has reportedly pulled Hampton Creek products from its stores and even disabled cashiers’ ability to scan these items at checkout. Why? That’s a more complicated question. The retailer …

    Source: The Consumerist
  • Lincoln-Sudbury Claims State Title to Round Out Final Nike/USL HSB Top 25
    By mschneider - Tuesday Jun 20, 2017

    Source: US Lacrosse Magazine
  • Food & Wine Magazine Will Leave New York for Alabama
    By STEPHANIE STROM - Friday Jun 23, 2017

    The move reflects a changing business in which traditional food magazines, and a Manhattan address, are less important.

    Source: NYT > Home Page
  • Needham Joins Final Nike/USL HSG Top 25 With Upset of Longmeadow
    By mschneider - Tuesday Jun 20, 2017

    Source: US Lacrosse Magazine
  • “It’s Shame On Us If We Blow It”: Highlights From NY Seizes the Momentum
    By Ben Fidler - Wednesday Jun 7, 2017

    Mike Foley, a drug industry veteran and director of the Tri-Institutional Therapeutics Discovery Institute, has a pointed message for the New York life sciences industry: Don’t waste the moment. Changing the course of New York biotech has been a saga that dates back to the 1990s, and as Xconomy has detailed, progress has been made […]

    Source: Xconomy New York
  • “It’s Shame On Us If We Blow It”: Highlights From NY Seizes the Momentum
    By Ben Fidler - Wednesday Jun 7, 2017

    Mike Foley, a drug industry veteran and director of the Tri-Institutional Therapeutics Discovery Institute, has a pointed message for the New York life sciences industry: Don’t waste the moment. Changing the course of New York biotech has been a saga that dates back to the 1990s, and as Xconomy has detailed, progress has been made […]

    Source: Xconomy VC, Deals, & Startups Feed
  • Expanding Teladoc Adds Network, Tech With $440M Best Doctors Deal
    By David Holley - Tuesday Jun 20, 2017

    Dallas—In Teladoc’s acquisition of Boston-based Best Doctors—a $440 million cash-and-stock deal that the companies announced Monday—Teladoc (NYSE: TDOC) is gaining a business that lets it offer more specialization in its telemedicine services. Best Doctors connects individuals who have tough decisions to make about treatments—or who want a second opinion about a diagnosis—with top-rated doctors worldwide. […]

    Source: Xconomy New York
  • Expanding Teladoc Adds Network, Tech With $440M Best Doctors Deal
    By David Holley - Monday Jun 19, 2017

    Dallas—In Teladoc’s acquisition of Boston-based Best Doctors—a $440 million cash-and-stock deal that the companies announced Monday—Teladoc (NYSE: TDOC) is gaining a business that lets it offer more specialization in its telemedicine services. Best Doctors connects individuals who have tough decisions to make about treatments—or who want a second opinion about a diagnosis—with top-rated doctors worldwide. […]

    Source: Xconomy VC, Deals, & Startups Feed